
- About WXPress
- WXPress is your window into the world of WuXi AppTec and our global partners.
- Sitemap
- Events
- Contact
- Please reach out with any business inquires.
- communications@wuxiapptec.com
January 11, 2022 ~ January 11, 2022
8am - 11:30am PST | 7pm - 10:30pm PST
11am - 2:30pm EST | 10pm - 1:30am EST
Dear Colleagues & Friends,
We are honored to have been able to unite thousands of colleagues this year from around the world for the inaugural WuXi – A*STAR Healthy Aging Forum on January 11th alongside the 2022 WuXi Global Forum. Together, we were able to inspire innovative thinking and tangible solutions for a future where everyone can enjoy a longer and healthier life.
This complimentary event brought together nearly 30 leading voices at the forefront of tackling aging challenges, convened top executives from the life science industries, preeminent researchers, and key stakeholders to promote partnerships and actionable approaches in the new era of healthy aging, uniting thousands of colleagues around the world. To our esteemed guest speakers, THANK YOU!
Special thanks to our supportive partners: BioCentury, Biocom California, Clarivate, California Life Sciences, Endpoints News, Fierce Biotech, GEN, MBC BioLabs, Medicon Valley Alliance, QB3, and Swiss Biotech Association, UK BioIndustry Association.
Please scroll down for the final agenda, or click the links below to watch this Forum on-demand (All day events or individual sessions).
– Conference Welcome and Opening Remarks
– Spotlight on Alzheimer’s Disease
– Healthy Aging: Singapore’s Perspectives
– Prevention. Prediction. Personalization.
– The Next Frontiers in Tackling Age-Related Disorders
– How Will Technologies Shape the New Era of Healthy Aging
Thank you again, and make sure to follow us on Twitter and LinkedIn to stay up-to-date on upcoming WuXi AppTec news and events.
Hui Cai, Program Chair, VP and Head of Content, WuXi AppTec
Steve Yang, Co-CEO, WuXi AppTec
Frederick Chew, CEO, A*STAR; Chief, Public Sector Science & Technology Policy & Plans Office, Prime Minister’s Office of Singapore
George Vradenburg, Convener, The Global CEO Initiative on Alzheimer’s Disease; Founding Chairman, Davos Alzheimer’s Collaborative; Chairman & Co-Founder, UsAgainstAlzheimer’s
Kate Bingham, Managing Partner, SV Health Investors
Luigi Ferrucci, Scientific Director, National Institute on Aging of NIH
Paul Irving, Chairman, Milken Institute Center for the Future of Aging; Distinguished Scholar-in-Residence, USC Davis School of Gerontology
Session Leader: Michal Preminger, Regional Head, Johnson & Johnson Innovation East North America
Niranjan Bose, Managing Director, Health & Life Sciences, Gates Ventures
Ivan Cheung, Chairman, Eisai Inc; Global President of Neurology Business Group, Eisai Co Ltd
George Vradenburg, Convener, The Global CEO Initiative on Alzheimer’s Disease; Founding Chairman, Davos Alzheimer’s Collaborative; Chairman & Co-Founder, UsAgainstAlzheimer’s
Session Leader: Stacie Weninger, President of F-Prime Biomedical Research Initiative (FBRI)
Linda Partridge, Founding Director, Max Planck Institute for Biology of Ageing; Professor, Institute of Healthy Ageing, and GEE, UCL
Eric Verdin, CEO & President, Buck Institute for Research on Aging
Session Leader: Sebastien Thuault, Chief Editor, Nature Aging
Yap-Seng Chong, Dean, NUS Yong Loo Lin School of Medicine; Chief Clinical Officer, A*STAR
Daniel Fung, CEO, Institute of Mental Health in Singapore
Chien-Earn Lee, Deputy Group CEO (Regional Health System), SingHealth
Andrea Maier, Co-Director, Centre for Healthy Longevity, National University Health System, Singapore
Session Leader: Brian Kennedy, Distinguished Professor in Biochemistry and Physiology, the Yong Loo Lin School of Medicine, National University of Singapore
A conversation between Scott Berkowitz, VP & Chief Population Health Officer, Johns Hopkins Medicine; Associate Professor of Cardiology, Johns Hopkins University and Henry Brodaty, Professor of Ageing and Mental Health; Co-Director, CHeBA (Centre for Healthy Brain Ageing), UNSW Sydney
Rita Balice-Gordon, CEO, Muna Therapeutics
Marco Boorsma, General Partner at Forbion
Jens Eckstein, Managing Partner, Apollo Health Ventures
Kristen Fortney, Co-Founder and CEO, BioAge
James Peyer, Founder & CEO, Cambrian Biopharma
Session Leader: Dave Madge, VP of Discovery Services, WuXi AppTec
Joseph Coughlin, Founder and Director, MIT AgeLab




























